AYALEW TEFFERI, M.D.
Osteopathic Medicine at 1 St, Rochester, MN
License number
Minnesota 30577
Category
Osteopathic Medicine
Type
Hematology
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511
Organization information
See more information about AYALEW TEFFERI at bizstanding.comAyalew Tefferi MD
200 1 St SW, Rochester, MN 55905
Industry:
Internist
Phone:
(800) 660-4582 (Phone)
Description:
There are 82 doctors at this site. Surgery is not performed at this site.
Ayalew . Tefferi
Mayo Clinic - Ayalew Tefferi MD
200 1 St SW #W4, Rochester, MN 55905
Categories:
Physicians & Surgeons
Phone:
(507) 284-2511 (Phone)
Professional information
Dr. Ayalew Tefferi, Rochester MN - MD (Doctor of Medicine)
Specialties:
Hematology
Address:
Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Certifications:
Hematology, 1988, Internal Medicine, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mayo Clinic
200 1St St SW, Rochester 55905
Mayo Clinic Saint Marys Hospital
1216 2Nd St South #West, Rochester 55902
North Memorial Medical Center
3300 Oakdale Ave North, Robbinsdale 55422
200 1St St SW, Rochester 55905
Mayo Clinic Saint Marys Hospital
1216 2Nd St South #West, Rochester 55902
North Memorial Medical Center
3300 Oakdale Ave North, Robbinsdale 55422
Education:
Medical School
University Of Athens, School Of Health Sciences
Graduated: 1982
Mayo Grad School Med/Mayo Fndn
St Joseph Hospital
University Of Athens, School Of Health Sciences
Graduated: 1982
Mayo Grad School Med/Mayo Fndn
St Joseph Hospital
Ayalew Tefferi, Rochester MN
Specialties:
Internal Medicine, Hematology, Hematology & Oncology, Hematology
Work:
Mayo Medical School
200 1St St Sw, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
Education:
University Of Athens (1981)
Compositions And Methods For Treating Myelofibrosis
US Patent:
2013025, Sep 26, 2013
Filed:
May 6, 2013
Appl. No.:
13/888073
Inventors:
Janice CACACE - Miami FL, US
Ayalew TEFFERI - Rochester MN, US
Ayalew TEFFERI - Rochester MN, US
Assignee:
TARGEGEN, INC. - Bridgewater NJ
International Classification:
A61K 31/506
US Classification:
514275
Abstract:
Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof.
Compositions And Methods For Treating Myelofibrosis
US Patent:
2013024, Sep 19, 2013
Filed:
May 6, 2013
Appl. No.:
13/888096
Inventors:
Janice CACACE - Miami FL, US
Ayalew TEFFERI - Rochester MN, US
Ayalew TEFFERI - Rochester MN, US
Assignee:
TargeGen, Inc. - Bridgewater NJ
International Classification:
A61K 31/506, A61K 9/48
US Classification:
424452, 514275
Abstract:
Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof.